Antibody & TIDES Summit 2025

Jean Ge will speak on two panels at the Antibody & TIDES Summit 2025.

Navigating Regulatory Challenges in Oligonucleotide Therapeutics and Associated IP Considerations

September 9, 2025 l 11:30am-12:20pm

Panelists: 

• Jean Ge | Patent Attorney, Wolf Greenfield
• Maria Liljevald | Head of Global Regulatory Affairs, Ribocure Pharmaceuticals AB
• Sonja Merkas | Founder, Livinovea

Peptide vs. Oligo: Which Modality Wins in the Next 10 Years?

September 10, 2025 l 9:00-9:50am 

Panelists: 

• Jean Ge | Patent Attorney, Wolf Greenfield
• Dr David Gilot | Director, AstraZeneca
• Dr Piotr Putaj | Director Oligonucleotide Chemistry, Vico Therapeutics
• Troels Koch | Chief Technology Officer, MiNA Therapeutics